Shanghai Pharmaceuticals Holding Co., Ltd Stock Other OTC
Stocks
SHPMY
US81943R1005
Pharmaceuticals
OTC Markets Traded| Market Cap | 54.91B 8.1B 7.1B 6.58B 6.05B 11.45B 775B 11.67B 78.4B 30.75B 381B 30.41B 29.74B 1,314B | P/E 2026 * |
11.3x | P/E 2027 * | 10.2x |
|---|---|---|---|---|---|
| Enterprise Value | 59.58B 8.79B 7.71B 7.14B 6.57B 12.42B 841B 12.66B 85.07B 33.37B 413B 32.99B 32.27B 1,426B | EV / Sales 2026 * |
0.2x | EV / Sales 2027 * | 0.21x |
| Free-Float |
41.21% | Yield 2026 * |
2.65% | Yield 2027 * | 2.92% |
| 1 day | -3.18% |
| Manager | Title | Age | Since |
|---|---|---|---|
Yong Zhong Li
PSD | President | 56 | 29/06/2023 |
Bo Shen
DFI | Director of Finance/CFO | 53 | 05/06/2013 |
Xue Jun Cai
CTO | Chief Tech/Sci/R&D Officer | 63 | 01/10/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Bo Shen
BRD | Director/Board Member | 53 | 28/06/2016 |
Yong Zhong Li
BRD | Director/Board Member | 56 | 27/06/2019 |
You Li Xu
CHM | Chairman | 51 | 29/06/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.18% | +4.04% | - | - | 8.1B | |
| +0.78% | +3.58% | +14.47% | +98.27% | 95.1B | |
| -0.91% | -1.63% | +45.16% | +150.12% | 54.72B | |
| +0.17% | +3.72% | +4.09% | +279.87% | 23.3B | |
| -0.75% | -4.20% | -27.34% | -35.59% | 7.54B | |
| +1.01% | -0.06% | -11.13% | -27.46% | 6.71B | |
| -1.55% | -2.79% | +20.10% | +34.64% | 6.16B | |
| +0.81% | +1.69% | -0.23% | +23.87% | 5.36B | |
| +1.00% | +0.20% | -5.24% | -6.75% | 3.72B | |
| +1.28% | -0.97% | +12.27% | +16.59% | 3.36B | |
| Average | -0.08% | +0.33% | +5.80% | +59.28% | 22.89B | |
| Weighted average by Cap. | +0.30% | +1.60% | +18.48% | +116.53% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 297B 43.84B 38.45B 35.62B 32.77B 61.98B 4,196B 63.19B 424B 166B 2,061B 165B 161B 7,117B | 315B 46.49B 40.78B 37.77B 34.75B 65.73B 4,450B 67.01B 450B 177B 2,185B 175B 171B 7,546B |
| Net income | 5.35B 788M 691M 640M 589M 1.11B 75.45B 1.14B 7.63B 2.99B 37.05B 2.96B 2.9B 128B | 5.6B 826M 725M 671M 618M 1.17B 79.08B 1.19B 8B 3.14B 38.84B 3.1B 3.03B 134B |
| Net Debt | 4.67B 689M 604M 560M 515M 974M 65.93B 993M 6.67B 2.62B 32.38B 2.59B 2.53B 112B | 12.67B 1.87B 1.64B 1.52B 1.4B 2.64B 179B 2.69B 18.09B 7.09B 87.8B 7.01B 6.86B 303B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Choose MarketScreener 
